TrialBone marrow transplantation2017

Low incidence of severe cGvHD and late NRM in a phase II trial of thymoglobulin, tacrolimus and sirolimus for GvHD prevention.

Z Al-Kadhimi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.